Calegari, Maria Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.792
AS - Asia 939
EU - Europa 856
SA - Sud America 207
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 46
OC - Oceania 2
Totale 3.901
Nazione #
US - Stati Uniti d'America 1.739
SG - Singapore 425
DE - Germania 195
IT - Italia 170
VN - Vietnam 161
BR - Brasile 160
CN - Cina 154
PL - Polonia 106
SE - Svezia 96
FR - Francia 77
FI - Finlandia 50
GB - Regno Unito 45
IE - Irlanda 34
IN - India 34
ID - Indonesia 29
JP - Giappone 29
AR - Argentina 27
BD - Bangladesh 27
CA - Canada 22
HK - Hong Kong 19
MX - Messico 19
ZA - Sudafrica 17
UA - Ucraina 15
RU - Federazione Russa 14
TR - Turchia 13
ES - Italia 12
CI - Costa d'Avorio 8
EC - Ecuador 8
MA - Marocco 7
NL - Olanda 7
AT - Austria 6
IQ - Iraq 6
CZ - Repubblica Ceca 5
PK - Pakistan 5
SA - Arabia Saudita 5
IR - Iran 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
BE - Belgio 3
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
TN - Tunisia 3
VE - Venezuela 3
AU - Australia 2
BY - Bielorussia 2
CO - Colombia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
EU - Europa 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
NG - Nigeria 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DM - Dominica 1
GR - Grecia 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.845
Città #
Ashburn 591
Singapore 256
Chandler 146
San Jose 138
Warsaw 98
Rome 52
Hanoi 50
Ho Chi Minh City 45
Los Angeles 45
Beijing 43
Munich 39
New York 34
Dublin 32
Helsinki 30
Fairfield 27
Houston 27
Wilmington 26
Chicago 25
Lauterbourg 24
Council Bluffs 23
Milan 23
Tokyo 22
Jakarta 19
Boston 18
Hong Kong 17
Hyderabad 17
Ann Arbor 16
Dearborn 16
Frankfurt am Main 16
San Mateo 16
Woodbridge 16
Hefei 15
São Paulo 15
The Dalles 15
Santa Clara 14
Seattle 14
Cambridge 13
Cattolica 13
Orem 13
Princeton 12
Johannesburg 11
Paris 11
Marseille 10
Jacksonville 9
Poplar 9
Redwood City 9
Turku 9
Abidjan 8
Atlanta 8
Dallas 8
Mexico City 8
Moscow 8
Nanjing 8
Boardman 7
Brooklyn 7
Buenos Aires 7
Da Nang 7
Hải Dương 7
Lappeenranta 7
Phoenix 7
Buffalo 6
Izmir 6
Montreal 6
Washington 6
Bari 5
Chennai 5
Guangzhou 5
Kent 5
London 5
Manchester 5
Mountain View 5
Nürnberg 5
Querétaro 5
Shanghai 5
St Louis 5
Toronto 5
Amsterdam 4
Bexley 4
Brasília 4
Denver 4
Lawrence 4
Roubaix 4
Salt Lake City 4
San Francisco 4
Shenyang 4
Thái Bình 4
Andover 3
Augusta 3
Belo Horizonte 3
Berlin 3
Bremen 3
Curitiba 3
Dakar 3
Elk Grove Village 3
Hangzhou 3
Islamabad 3
Leawood 3
Legnano 3
Manassas 3
Newark 3
Totale 2.402
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 618
Diagnosis and management of breast lymphoma: A single-institution retrospective analysis 281
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 236
Mastectomy in precision oncology era: Myth or reality? 192
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 183
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 160
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 148
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 142
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 138
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 137
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 135
Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: A change of paradigm in a case series 123
Clinical and Molecular Features in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinosis from Colorectal Cancer 123
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 122
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 121
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 116
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 112
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study 103
Combination of endoscopic ultrasound-guided radiofrequency ablation and adaptive radiation therapy for the treatment of lymph node metastases from colon adenocarcinoma: A case report 103
LUX-Lung 7: is there enough data for a final conclusion? 101
PTEN in colorectal cancer: Shedding light on its role as predictor and target 94
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 92
Gemcitabine versus FOLFIRINOX in patients with advanced pancreatic adenocarcinoma hENT1-positive: everything was not too bad back when everything seemed worse 88
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC 79
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 63
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 57
Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer 15
Molecular and Clinical Profile of a RET-Rearranged Colorectal Cancer With Prolonged Response to Platinum Therapy and Subsequent Targeted Treatment With Selpercatinib 15
Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis 4
Totale 3.901
Categoria #
all - tutte 14.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022144 0 6 5 13 2 4 5 19 5 15 36 34
2022/2023365 47 52 19 57 15 38 20 38 33 10 15 21
2023/2024642 7 46 9 6 10 38 232 252 2 8 16 16
2024/2025442 5 11 36 14 30 14 14 8 45 52 108 105
2025/20261.699 191 79 114 288 307 72 237 95 127 95 49 45
2026/2027110 40 70 0 0 0 0 0 0 0 0 0 0
Totale 3.901